SynthesisFrontiers in psychology2026
Optimal doses of different exercise types for improving depressive symptoms in climacteric women: a systematic review and network meta-analysis.
Synthesis in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exercise dose and triglyceride reduction in postmenopausal women: a systematic review and model-based network meta-analysis.Frontiers in physiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression in climacteric women-defined as females transitioning from perimenopause to postmenopause (perimenopause: declining ovarian function with fluctuating and decreasing estrogen levels; postmenopause: cessation of menstruation for ≥12 months with persistently low estrogen levels)-impairs quality of life and burdens families and healthcare systems. Exercise, a proven non-pharmacological intervention for menopausal depression, has been understudied for "optimal dosage across exercise types"-previous research either focused on activity-depression associations or ignored dosage when selecting exercise types. This systematic review and network meta-analysis addresses this gap by comparing optimal doses of four exercises (aerobic, multi-mode, stretching, and mind-body) to establish an evidence-based "exercise type-dose" hierarchy for clinical practice. Methods: We systematically searched PubMed, Cochrane Library, Embase, and Web of Science (inception to September 2025) for randomized controlled trials (RCTs) on exercise for climacteric women's depression. Two researchers independently screened studies, extracted data, and assessed quality via Cochrane RoB2. Bayesian network meta-regression (MBNMA, R software) modeled dose-response relationships, and SUCRA ranked intervention efficacy to identify optimal doses. Results: Twenty-three RCTs were included. The most favorable ranges observed in available RCTs appear to be: aerobic exercise (600-1,100 MET-min/week, slight saturation); multi-mode exercise (1000-1,500 MET-min/week); stretching exercise (900-1,200 MET-min/week, U-shaped curve); mind-body exercise (1000-1,500 MET-min/week, limited data >1,500 MET-min/week). Three sessions/week and 12-week intervention aligned with these most favorable ranges. Conclusion: Aerobic (600-1,100 MET-min/week), multi-mode (1000-1,500 MET-min/week), and stretching (900-1,200 MET-min/week) exercises are most effective for alleviating climacteric depression. Clinicians should prioritize aerobic exercise; multi-mode exercise may improve adherence for those seeking variety. Key challenges include supplementing high-dose mind-body exercise data (>1,500 MET-min/week) and supporting long-term adherence amid menopausal physiological changes. Systematic review registration: This study has been registered on PROSPERO (CRD420251162965).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.